ArticleBritish journal of cancer2012

Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma.

K Hirashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.